Bayer Sharpens US Focus As Pressure Tightens On Drug Makers
US To Account For More Than Half Of New Product Sales
The German company’s two top sellers are marketed by partners in the US, but Bayer will pocket all US sales from its four newest products, at a time when pressures are mounting at home and abroad.